← Back to Search

Diagnostic Test

Velacur by Sonic Incytes for Non-alcoholic Fatty Liver Disease

N/A
Waitlist Available
Led By Samer Gawrieh, MD
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one day
Awards & highlights

Study Summary

This trial will help assess if a certain kind of liver cell can be used to help diagnose non-alcoholic fatty liver disease and its severity.

Eligible Conditions
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Non-alcoholic Fatty Liver Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one day
This trial's timeline: 3 weeks for screening, Varies for treatment, and one day for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Liver Stiffness Measured by Transient Elastography
Liver Stiffness Measured by Velacur
Other outcome measures
Correlation of Velacur Measurements to Non-Invasive Blood Markers for Predicting Advanced Fibrosis

Trial Design

1Treatment groups
Experimental Treatment
Group I: Velacur by Sonic IncytesExperimental Treatment1 Intervention
Patients with known or suspected Non-Alcoholic Fatty Liver Disease (NAFLD) or Non-Alcoholic Steatohepatitis (NASH) will be scanned with Velacur for assessment of liver fibrosis.

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
980 Previous Clinical Trials
983,125 Total Patients Enrolled
6 Trials studying Non-alcoholic Fatty Liver Disease
2,589 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Sonic IncytesIndustry Sponsor
5 Previous Clinical Trials
674 Total Patients Enrolled
3 Trials studying Non-alcoholic Fatty Liver Disease
464 Patients Enrolled for Non-alcoholic Fatty Liver Disease
Samer Gawrieh, MD4.67 ReviewsPrincipal Investigator - Indiana University School of Medicine
Indiana University Health, North Hospital, Indiana University Health, University Hospital
Medical School - University of Aleppo Faculty of Medicine, Doctor of Medicine
John H. Stroger, Jr. Hospital of Cook County, Residency in Internal Medicine
2 Previous Clinical Trials
470 Total Patients Enrolled
1 Trials studying Non-alcoholic Fatty Liver Disease
400 Patients Enrolled for Non-alcoholic Fatty Liver Disease
5Patient Review
I appreciate that he takes the time to listen to me.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open to the public for this clinical investigation?

"Per information found on clinicaltrials.gov, this clinical trial is actively searching for participants as of January 25th 2022 - the date it was last updated. The original posting was made on February 1st 2021."

Answered by AI

How much recruitment is the clinical trial receiving?

"Affirmative, the clinicaltrials.gov database confirms that this medical trial is currently in its recruitment phase; it was initially posted on February 1st 2021 and most recently updated on January 25th 2022. 100 patients are being sought out at a single research site."

Answered by AI

Who else is applying?

What state do they live in?
Minnesota
Other
California
Illinois
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?
3+
0
What site did they apply to?
Indiana University Division of Gastroenterolgy and Hepatology

Why did patients apply to this trial?

Concerned about my health. Interested in learning more about fatty liver, plus I have stage 2 scared lived too. I don't understand how I got all this. And have CDK stage 3 too, again don't understand how.
PatientReceived no prior treatments

What questions have other patients asked about this trial?

Please explain about the screening process, what is involved, time, etc. My husband would be coming with me so need to know if this is a couple of hours, a day or??? What is the length of the trial?
PatientReceived 1 prior treatment

How responsive is this trial?

Most responsive sites:
  1. Indiana University Division of Gastroenterolgy and Hepatology: < 24 hours
Average response time
  • < 1 Day
Typically responds via
Email
Recent research and studies
clinicaltrials.govStudy
Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease
Samer Gawrieh 2021. "Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04576923.
~9 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top